Canada’s healthcare systems are under increasing pressure: a rapidly aging population, new demands for services, fiscal challenges, and awkward interfaces between publicly and privately funded services are among the challenges to which Canadians must adapt. Sound research and advice from independent sources will be integral to achieving desirable policy outcomes. The C.D. Howe Institute’s Healthcare Policy Initiative is a four-year program to produce research, analysis and events to raise the level of debate around Canadian healthcare and to help motivate policy improvements. The program will address critical issues such as: international lessons on financing and incentives; defining the services provided under public plans; incentives and funding arrangements for hospitals and healthcare providers; federal and provincial policy on pharmaceuticals; options for primary-care reform; access and quality of care. As with all the Institute’s work, the program aims to provide research that is rigorous, evidence-based, and peer-reviewed, recommendations that are relevant, constructive, and timely, and communications that are clear, authoritative and practical.

Co-Chairs

Tom Closson

Tom Closson

Former President & CEO, Ontario Hospital Association; President and CEO, Tom Closson Consulting
Dr. Brian Postl

Dr. Brian Postl

Dean, Faculty of Medicine, University of Manitoba

Members

Mehmood Alibhai

Mehmood Alibhai

Director, Patient Access & Healthcare Policy, Boehringer-Ingelheim Canada Ltd
Richard Alvarez

CEO, Richard Alvarez & Associates

Andrea Anonychuk

Health Innovation Manager, Abbott Laboratories

Lesia Babiak

Executive Director, Government Affairs & Policy (Canada), Johnson & Johnson Corporate
Åke Blomqvist

Adjunct Research Professor, Carleton University

Steve Bradie

President and CEO, Green Shield Canada
William Charnetski

William Charnetski

Chief Health Innovation Strategist for Ontario
Candace Chartier

Candace Chartier

CEO, Ontario Long Term Care Association
Denise Cloutier

Denise Cloutier

Directrice Nationale, Politiques Santé & Économiques, Pfizer Canada

Related Research